QIAGEN N.V. develops and provides sample and assay technologies for molecular diagnostics, applied testing, and academic research. The company offers products for nucleic acid extraction, next-generation sequencing, digital PCR, and various applications in oncology, infectious disease testing, and forensics. QIAGEN serves customers in the healthcare, pharmaceutical, and biotechnology sectors, operating globally to support laboratories and research institutions.
